Everolimus for social skills in PTEN syndrome
Part of Cancer, Genetic & congenital, Mental health clinical trials.
This study tests whether a pill called everolimus can help improve social abilities in people with PTEN gene changes. Participating may help you or your child gain better social functioning, and the study provides close monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed PTEN gene change (PTEN hamartoma tumor syndrome, PHTS).
- You have at least moderate social difficulties, like trouble interacting with others.
- You speak English fluently.
- If you are a female who could become pregnant, you must use contraception and not plan to get pregnant.
- You have a family member or caregiver who can provide reports about you and help with transportation.
- You are medically stable and able to take pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether sirolimus can be used safely and works over time for LAM, a rare lung disease. You may be able to join if you already use (or cannot use) certain lung-targeting medicines called mTOR inhibitors, and if you can do regular clinic visits and breathing tests.
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
This trial tests a pill called everolimus to see if it can shrink or control abnormal blood vessel growths (vascular anomalies) that have not responded to other treatments. It may offer a new option for patients aged 1 year and older.
This early-phase study tests how a medicine called rapalog affects the body in generally healthy middle-aged adults. It may help researchers understand safety and dosing, but it’s not meant to treat an existing disease.
This study tests whether the medicine everolimus (taken as a pill) can safely reduce seizures in adults with focal epilepsy that hasn't been controlled by other treatments. You would continue your current seizure medicines and add everolimus.
This trial tests a drug called everolimus for people with advanced colorectal cancer that has a specific change in a gene called CDK12. It aims to see if this drug can slow down the cancer when other treatments have stopped working.
Hear when a new PTEN Hamartoma Tumor Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.